Literature DB >> 17886249

Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma.

Laurent Greillier1, Arnaud Cavailles, Anne Fraticelli, Arnaud Scherpereel, Fabrice Barlesi, Gianfranco Tassi, Pascal Thomas, Philippe Astoul.   

Abstract

BACKGROUND: Promising results with trimodality therapy combining surgery, chemotherapy, and radiotherapy have been obtained in the management of patients with malignant pleural mesothelioma (MPM). However, the histologic subtype has to be taken into account because of its influence on prognosis. The aim of the current study was to analyze retrospectively the accuracy, sensitivity, and specificity of preoperative thoracoscopy for diagnosis of the histologic subtype of MPM.
METHODS: The histologic reports from all consecutive patients undergoing 'intent-to-treat' surgery from 3 institutions as well as the initial pathologic diagnosis obtained using thoracoscopy were reviewed and compared after institutional review board approval. All cases of MPM were confirmed by a panel of pathologists.
RESULTS: Ninety-five patients were included in the current study. Of these 95 patients, 75 underwent extrapleural pneumonectomy, 9 patients underwent pleurectomy/decortication, and 11 patients underwent pleurectomy. Of the 95 patients with a final diagnosis of MPM, 80 (84.2%) were classified as having epithelial and 15 (15.8%) as having biphasic subtype. Among the 87 patients classified as having MPM of epithelial subtype after the initial thoracoscopy, 75 cases (86.2%) were confirmed to be a true histologic diagnosis and 12 cases (13.8%) were found to be of biphasic subtype at final diagnosis. One patient with a biphasic subtype at initial thoracoscopy was found to have MPM of epithelial subtype after surgery. The sensitivity and specificity values of an epithelial subtype diagnosis after thoracoscopy were 94% and 20%, respectively, with a positive predictive value of 86% and a negative predictive value of 37%. Conversely, the sensitivity and specificity values of a biphasic subtype diagnosis after thoracoscopy were 20% and 98%, respectively, with a positive predictive value of 75% and a negative predictive value of 87%.
CONCLUSIONS: Pleural biopsy performed using thoracoscopy is considered to be the cornerstone of the diagnosis and pleural staging of MPM. However, this procedure appears to be less efficient in diagnosing the histologic subtype as either epithelial or biphasic. (c) 2007 American Cancer Society.

Entities:  

Mesh:

Year:  2007        PMID: 17886249     DOI: 10.1002/cncr.23034

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

Review 1.  [Surgical therapy of malignant pleural mesothelioma].

Authors:  M Schirren; S Sponholz; S Oguzhan; A Fisseler-Eckhoff; A Fischer; J Schirren
Journal:  Chirurg       Date:  2016-05       Impact factor: 0.955

2.  Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy.

Authors:  Yeon-Hee Park; Jae-Woo Choi; Sang-Ok Jung; Min-Ji Cho; Da-Hyun Kang; Chae-Uk Chung; Dong-Il Park; Jae-Young Moon; Hee-Sun Park; Sung-Soo Jung; Ju-Ock Kim; Sun-Young Kim; Jeong-Eun Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-06-30

3.  Is There a Role for a Needle Thoracoscopic Pleural Biopsy under Local Anesthesia for Pleural Effusions?

Authors:  Ho Sung Son; Sung Ho Lee; Laleng Mawia Darlong; Jae Seong Jung; Kyung Sun; Kwang Taik Kim; Hee Jung Kim; Kanghoon Lee; Seung Hun Lee; Jong Tae Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-04-10

Review 4.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

5.  Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma.

Authors:  Lucian R Chirieac; Yin P Hung; Wai Chin Foo; Matthias D Hofer; Paul A VanderLaan; William G Richards; David J Sugarbaker; Raphael Bueno
Journal:  Cancer       Date:  2019-08-07       Impact factor: 6.860

6.  Cytological Diagnostic Procedures in Malignant Mesothelioma.

Authors:  Christian Biancosino; Lea Isabell Shari van der Linde; Guido Sauter; Florian Stellmacher; Marcus Krüger; Lutz Welker
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 7.  Management of malignant pleural effusion.

Authors:  Jack A Kastelik
Journal:  Lung       Date:  2013-01-13       Impact factor: 2.584

8.  Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Authors:  Andrew Churg; Richard Attanoos; Alain C Borczuk; Lucian R Chirieac; Françoise Galateau-Sallé; Allen Gibbs; Douglas Henderson; Victor Roggli; Valerie Rusch; Meagan J Judge; John R Srigley
Journal:  Arch Pathol Lab Med       Date:  2016-03-31       Impact factor: 5.534

9.  A new electrocautery pleural biopsy technique using an insulated-tip diathermic knife during semirigid pleuroscopy.

Authors:  Shinji Sasada; Kunimitsu Kawahara; Yoko Kusunoki; Norio Okamoto; Teruo Iwasaki; Hidekazu Suzuki; Masashi Kobayashi; Tomonori Hirashima; Kaoru Matsui; Mitsunori Ohta; Teruomi Miyazawa
Journal:  Surg Endosc       Date:  2009-01-01       Impact factor: 4.584

10.  Reproducibility of histological subtyping of malignant pleural mesothelioma.

Authors:  Luka Brčić; Marko Jakopović; Iva Brčić; Vlasta Klarić; Milan Milošević; Ana Sepac; Miroslav Samaržija; Sven Seiwerth
Journal:  Virchows Arch       Date:  2014-10-10       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.